LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024%

latanoprostene bunod ophthalmic solution 0.024% · Gland Pharma Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024%, covering 2018-06-06 to 2025-04-29. Get the full timeline:

Most recent: FDA Approved: LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% — Original Application (Gland Pharma Limited)